Integer Holdings Corp

Análisis de la acción Integer Holdings Corp (ITGR)

$126.700

0.000 (0.00%)Al cierre

Loading chart…
Máximo
126.830
Apertura
126.730
Precio medio ponderado por volumen
126.74
Volumen
764.08K
Capitalización
3.84B
Mínimo
126.700
Importe
96.84M
EV/EBITDA, TTM
17.06

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.

Análisis de IA of Integer Holdings Corp (ITGR)

Mantener

Integer Holdings Corp is currently a hold. The stock is trading at $126.70, very close to the acquisition price of $127, which limits upside potential. The RSI is at 71.16, indicating it is overbought, and the forward P/E ratio is 22.42, suggesting it may be fairly valued at this price point. The primary risk is the recent downgrade by analysts, which reflects concerns about future performance post-acquisition.

Recomendaciones de analistas (5)

-31.93% Potencial de caída
Mantener
2 Comprar
3 Mantener
0 Vender
Actual: 126.70
Mínimo
75.00
Promedio
86.25
Máximo
95.00

Benchmark

2026-08-13

Precio objetivo

—

Mantener

Piper Sandler

2026-08-03

Precio objetivo

$127

Neutral

KeyBanc

2026-08-03

Precio objetivo

$127

Sector Weight

BofA

2026-08-03

Precio objetivo

—

No Rating

Freedom Capital

2026-07-22

Precio objetivo

$112

Comprar

Métricas de valoración

El PER previsto actual de Integer Holdings Corp (ITGR) es 22.42, frente a su media de 5 años de 18.69.

PER previsto

Sobrevalorado
Media 5A P/E
18.69
P/E actual
22.42
Sobrevalorada
21.77
Infravalorada
15.61

EV/EBITDA previsto

Muy sobrevalorado
Media 5A EV/EBITDA
12.85
EV/EBITDA actual
17.06
Sobrevalorada
14.51
Infravalorada
11.18

Precio/ventas previsto

Valor razonable
Media 5A P/S
1.90
P/S actual
2.23
Sobrevalorada
2.24
Infravalorada
1.56

Escenarios de precio de Alphio AI para ITGR

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%ITGR

$140.04

Precio del escenario

B

Base

Base · 50%ITGR

$133.90

Precio del escenario

B

Bajista

Bajista · 25%ITGR

$130.08

Precio del escenario

Ballenas con ITGR en cartera

N

Nomura Holdings, Inc.

+ Con en carteraITGR

+2.59%

Rentabilidad a 3 meses

H

Heartland Advisors, Inc.

+ Con en carteraITGR

+1.11%

Rentabilidad a 3 meses

Cronología de eventos

2026-09-30 (ET)

08:30:00

Integer Holdings Receives Early Termination of Antitrust Waiting Period

2026-08-04 (ET)

06:30:00

Freedom Capital Downgrades Integer to Hold, Price Target $127

2026-08-03 (ET)

17:00:00

U.S. Stocks Rise as Middle East Tensions Ease, Oil Prices Drop 5%

17:00:00

Oppenheimer Downgrades Integer to Perform

12:00:00

Amazon's Market Cap Surpasses $3 Trillion

Noticias

Preguntas frecuentes sobre ITGR, respondidas por Alphio AI

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Integer Holdings Corp is currently a hold. The stock is trading at $126.70, very close to the acquisition price of $127, which limits upside potential. The RSI is at 71.16, indicating it is overbought, and the forward P/E ratio is 22.42, suggesting it may be fairly valued at this price point. The primary risk is the recent downgrade by analysts, which reflects concerns about future performance post-acquisition.

5 analysts cover ITGR: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 86.25.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar